TEVA PHARMACEUTICAL INDS LTD's ticker is and the CUSIP is 881624909. A total of 8 filers reported holding TEVA PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,341 | +135.8% | 1,308,000 | +74.1% | 0.01% | +100.0% |
Q2 2023 | $5,658 | +24.0% | 751,500 | +45.7% | 0.01% | +25.0% |
Q1 2023 | $4,563 | -23.8% | 515,700 | -21.5% | 0.00% | -42.9% |
Q4 2022 | $5,990 | -99.9% | 656,800 | -25.6% | 0.01% | -12.5% |
Q3 2022 | $7,120,000 | -27.6% | 882,300 | -32.5% | 0.01% | -20.0% |
Q2 2022 | $9,830,000 | -6.2% | 1,307,300 | +17.1% | 0.01% | 0.0% |
Q1 2022 | $10,482,000 | -30.8% | 1,116,400 | -41.0% | 0.01% | -33.3% |
Q4 2021 | $15,158,000 | +38.9% | 1,892,400 | +72.0% | 0.02% | +50.0% |
Q3 2021 | $10,912,000 | +0.8% | 1,100,000 | +0.6% | 0.01% | 0.0% |
Q2 2021 | $10,827,000 | +54.3% | 1,093,700 | +17882.6% | 0.01% | -23.1% |
Q1 2021 | $7,018,000 | +26.9% | 6,082 | +6.1% | 0.01% | +85.7% |
Q4 2020 | $5,531,000 | -11.1% | 5,732 | -17.0% | 0.01% | -12.5% |
Q3 2020 | $6,220,000 | -61.9% | 6,904 | -47.9% | 0.01% | -69.2% |
Q2 2020 | $16,327,000 | +32.0% | 13,242 | -3.9% | 0.03% | +18.2% |
Q1 2020 | $12,372,000 | +46.4% | 13,778 | +59.8% | 0.02% | +22.2% |
Q4 2019 | $8,448,000 | +77.0% | 8,621 | +24.3% | 0.02% | +28.6% |
Q3 2019 | $4,773,000 | +5.3% | 6,938 | +41.3% | 0.01% | +16.7% |
Q2 2019 | $4,531,000 | +27.3% | 4,910 | +116.3% | 0.01% | +20.0% |
Q1 2019 | $3,559,000 | -67.3% | 2,270 | -67.8% | 0.01% | -68.8% |
Q4 2018 | $10,886,000 | +25.3% | 7,060 | +75.1% | 0.03% | +14.3% |
Q3 2018 | $8,687,000 | +6.8% | 4,033 | +20.6% | 0.03% | -12.5% |
Q2 2018 | $8,132,000 | +5923.7% | 3,344 | +102.5% | 0.03% | +433.3% |
Q1 2018 | $135,000 | -87.5% | 1,651 | -68.9% | 0.01% | -87.2% |
Q4 2017 | $1,084,000 | +406.5% | 5,310 | +2.0% | 0.05% | +422.2% |
Q3 2017 | $214,000 | -69.0% | 5,208 | +12.7% | 0.01% | -70.0% |
Q2 2017 | $691,000 | +185.5% | 4,620 | +72.5% | 0.03% | +200.0% |
Q1 2017 | $242,000 | +168.9% | 2,679 | -34.5% | 0.01% | +100.0% |
Q4 2016 | $90,000 | +221.4% | 4,091 | +59.4% | 0.01% | +150.0% |
Q3 2016 | $28,000 | -75.7% | 2,566 | -0.3% | 0.00% | -75.0% |
Q2 2016 | $115,000 | +6.5% | 2,574 | +39.2% | 0.01% | -11.1% |
Q1 2016 | $108,000 | -87.2% | 1,849 | -42.1% | 0.01% | -86.4% |
Q4 2015 | $846,000 | +354.8% | 3,193 | -2.7% | 0.07% | +371.4% |
Q3 2015 | $186,000 | -17.7% | 3,282 | +101.0% | 0.01% | -26.3% |
Q2 2015 | $226,000 | -36.7% | 1,633 | +26.4% | 0.02% | -54.8% |
Q1 2015 | $357,000 | +65.3% | 1,292 | +326.4% | 0.04% | +61.5% |
Q4 2014 | $216,000 | – | 303 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Capital Markets Trading UK LLP | 1,229,400 | $10,880 | 0.18% |
Ion Asset Management Ltd. | 12,603 | $718 | 0.08% |
GROUP ONE TRADING, L.P. | 1,316,700 | $11,652,795 | 0.04% |
SIMPLEX TRADING, LLC | 515,700 | $4,563 | 0.00% |
IMC-Chicago, LLC | 207,400 | $1,835,490 | 0.00% |
JANE STREET GROUP, LLC | 354,100 | $3,133,785 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
JPMORGAN CHASE & CO | 256,900 | $2,274,000 | 0.00% |